Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3Phase 2/3 2Phase NA 1Phase 4 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Thoracic 1

Conditions

Breast Neoplasms 2Small Cell Lung Carcinoma 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 182Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × OTHER × EC regimen × Clear all
NCT00567554 2016-02-10

GeparQuinto

GBG Forschungs GmbH

Phase 3 Completed
2,600 enrolled
Breast

Breast Neoplasms

NCT00812266 2016-01-26

Topotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lung Cancer and Extensive Disease (SCLC-ED)

Danish Oncological Lung Cancer Group

Phase 3 Terminated
281 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT01917578 2013-08-06

BCSMANC

Shandong Cancer Hospital and Institute

Phase 3 Unknown
4 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡